Breast-cancer predisposition in multiple endocrine neoplasia type 1

New England Journal of Medicine

Volumn 371, Issue 6, 2014, Pages 583-584

  Dreijerink, Koen M A ^a   Goudet, Pierre ^b   Burgess, John R ^c   Valk, Gerlof D ^d  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b UNIVERSITÉ DE BOURGOGNE   (France)

^c UNIVERSITY OF TASMANIA   (Australia)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

METHIONINE; MEN1 PROTEIN, HUMAN; ONCOPROTEIN;

BREAST CANCER; BREAST CARCINOGENESIS; CANCER INCIDENCE; CANCER RISK; CANCER SUSCEPTIBILITY; CELL NUCLEUS; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GERMLINE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LETTER; MEN1 GENE; MULTIPLE ENDOCRINE NEOPLASIA; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; STANDARDIZED INCIDENCE RATIO; TISSUE MICROARRAY; TUMOR SUPPRESSOR GENE; ADULT; BREAST TUMOR; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; LONGITUDINAL STUDY; MIDDLE AGED; MUTATION; NETHERLANDS; PAGET NIPPLE DISEASE; PAPILLARY CARCINOMA; RISK;

ADULT; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, PAPILLARY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; MUTATION; NETHERLANDS; PROTO-ONCOGENE PROTEINS; RISK;

EID: 84905717730     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1406028     Document Type: Letter

References (5)

1. Thakker RV, Newey PJ, Walls GV, et al. Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab 2012;97:2990-3011.
2. Seigne C, Auret M, Treilleux I, et al. High incidence of mammary intraepithelial neoplasia development in Men1-disrupted murine mammary glands. J Pathol 2013;229:546-58.
3. Imachi H, Murao K, Dobashi H, et al. Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance. Breast Cancer Res Treat 2010;122:395-407.
4. Dreijerink KM, Mulder KW, Winkler GS, Höppener JW, Lips CJ, Timmers HT. Menin links estrogen receptor activation to histone H3K4 trimethylation. Cancer Res 2006;66:4929-35.
5. de Laat JM, Pieterman CR, Weijmans M, et al. Low accuracy of tumor markers for diagnosing pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1 patients. J Clin Endocrinol Metab 2013;98:4143-51.